News & Insights

News & Insights

< Back to Bio
Nicole Bronnimann

News 7 results

In the News · Source: Law360

July 22, 2024
Ashley Parrish, John Shakow and Nicole Bronnimann counsel AbbVie on its request before a Missouri federal court to block a state law that adds requirements to participate in the federal drug discount program

In the News · Source: Law.com

July 2, 2024
Ashley Parrish, John Shakow and Nicole Bronnimann counsel AbbVie in a dispute against the attorneys general in Kansas, Maryland, Minnesota, Mississippi and West Virginia over the federal 340B drug discount program

In the News · Source: Law360

April 8, 2024
Ashley Parrish, John Shakow and Nicole Bronnimann counsel AbbVie before a Louisiana federal court in a dispute involving the federal 340B drug discount program

In the News · Source: Law360, Daily Business Review, Daily Report, STAT and Top Class Actions

September 19, 2023
Charles Spalding, Brian Miller, Joe Akrotirianakis, Aaron Craig, Bruce Baber and Nicole Bronnimann represent Eli Lilly in a dispute with spas and other retailers that are allegedly selling counterfeit or compounded versions of its new drug Mounjaro

In the News · Source: Law360 and Bloomberg Law

January 30, 2023
K&S represents Novo Nordisk before the Third Circuit, which ruled in favor of the pharmaceutical company in its dispute with the U.S. Department of Health and Human Services over the Public Health Service Act's 340B program

In the News · Source: Patents: Mealey's Litigation Report

January 23, 2023
Jesse Snyder, Cason Hewgley, Nicole Bronnimann, Vanessa Yen and Evan Diamond submit an amicus brief on behalf of St. Jude Children's Research Hospital in support of Juno Therapeutics in a patent dispute before the U.S. Supreme Court

In the News · Source: Law360, Delaware Business Court Insider and New Jersey Law Journal

November 15, 2022
Ashley Parrish, Israel Dahan, John Shakow and Nicole Bronnimann advise Novo Nordisk before the Third Circuit in a dispute with the U.S. Department of Health and Human Services over the Public Health Service Act's 340B program